Replies to post #767 on Adamis Pharmaceuticals Corp (ADMP)

[value1008]

That's my sense, too. If that acquisition of the compounding co. is in fact able to bring in some operating income this year and next, then some of the dilution risk is off the table.

I think just one big reiteration by Michael Castor of Sio Capital for an Insider Monkey report will bring some "patient buyers" back in. The impatient have already left.... If some buying volume came back in, maybe not for 1-5 days, it might get some momo-traders to ride this up to $5 or $5.50 for an initial substantial rebound.